Well that's it - that's the quote that is just not believable. ( A participant can advance to the next cycle assuming they tolerate the drug and perceive a benefit (stable disease or improvement) if scans are performed. If the scans were showing this - Leo would announce it, not the team NP. Are you understanding that my point has nothing to do about possible efficacy of Kevetrin? It has to do with the suggestion that we as investors have been told by a team member that antitumor efficacy has been proven via scans. Doesn't happen in the world I live in. In my world, the CEO and the lead researcher very, very carefully construct this pr - because it is world changing. And such info is not given out in private email to individual. Ever.

I completely agree with you that such disease activity could be happening, and that Leo's pr's have been very positive. And this would also be his pr. This is what he's been working towards for years.